Fresh Recalls

FDAClass II · Drug · Recall D-0774-2026 · Recalled August 26, 2026

Acamprosate Calcium recall — Mylan Pharmaceuticals Inc

Agency report date: August 26, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Acamprosate Calcium
Company / brand
Mylan Pharmaceuticals
Lot / serial / date codes
Lot# 3227809; Expiry:10/2026; NDC #: 0378-6333-80
Distribution
US Nationwide.
Agency product description and boundaries

Acamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles, Rx only, Mylan Pharmaceuticals Inc., Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 266505, NDC 0378-6333-80.

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Failed Dissolution Specifications

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Acamprosate Calcium recall status

3. Open the official notice or contact

Official recall ID
D-0774-2026
Brand
All Mylan Pharmaceuticals recalls
Classification
Class II
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Morgantown, WV, United States
Firm address
3711 Collins Ferry Rd, 26505-2362

Identifying details (verbatim from the notice)

Product codes / lots
Lot# 3227809; Expiry:10/2026; NDC #: 0378-6333-80
Distribution
US Nationwide.
Firm notified the public via
Letter
FDA event ID
99483
Recall initiated
July 24, 2026
FDA classified
August 19, 2026
FDA report date
August 26, 2026

Other drug recalls from around the same time

Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked October 22, 2026 at 12:00 PM UTC. Record retrieved October 22, 2026 at 12:00 PM UTC.

Report a data error on this page